XML 62 R42.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule of Revenue by Segment and Reconciling Items | The table below presents a reconciliation of net revenues, significant expenses, net operating profit and depreciation and amortization by reportable segments for the years ended June 30, 2025, 2024 and 2023 (in thousands):
| 2025 |  | 2024 |  | 2023
Net revenue by segment |  |  |  |  |
Sleep and Breathing Health | $ | 4,504,890 |  |  | $ | 4,101,172 |  |  | $ | 3,725,017 |
Residential Care Software | 641,437 |  |  | 584,125 |  |  | 497,976 |
Total | $ | 5,146,327 |  |  | $ | 4,685,297 |  |  | $ | 4,222,993 |
Significant segment expenses |  |  |  |  |
Cost of Sales |  |  |  |  |
Sleep and Breathing Health | $ | 1,852,574 |  |  | $ | 1,782,023 |  |  | $ | 1,659,037 |
Residential Care Software | 195,043 |  |  | 190,186 |  |  | 174,718 |
Total | $ | 2,047,617 |  |  | $ | 1,972,209 |  |  | $ | 1,833,755 |
Selling, general, and administrative |  |  |  |  |
Sleep and Breathing Health | $ | 491,591 |  |  | $ | 451,334 |  |  | $ | 443,467 |
Residential Care Software(1) | 143,435 |  |  | 143,999 |  |  | 120,483 |
Total | $ | 635,026 |  |  | $ | 595,333 |  |  | $ | 563,950 |
Research and development |  |  |  |  |
Sleep and Breathing Health | $ | 196,340 |  |  | $ | 186,461 |  |  | $ | 175,393 |
Residential Care Software | 97,959 |  |  | 95,490 |  |  | 87,120 |
Total | $ | 294,299 |  |  | $ | 281,951 |  |  | $ | 262,513 |
Net operating profit by segment |  |  |  |  |
Sleep and Breathing Health | $ | 1,964,385 |  |  | $ | 1,681,354 |  |  | $ | 1,447,120 |
Residential Care Software | 205,000 |  |  | 154,450 |  |  | 115,655 |
Total | $ | 2,169,385 |  |  | $ | 1,835,804 |  |  | $ | 1,562,775 |
Reconciling items |  |  |  |  |
Corporate costs | $ | 406,114 |  |  | $ | 357,937 |  |  | $ | 338,362 |
Amortization of acquired intangible assets | 77,389 |  |  | 79,484 |  |  | 72,416 |
Restructuring expenses | — |  |  | 64,228 |  |  | 9,177 |
Masks with magnets field safety notification expenses (2) | (1,512) |  |  | 6,351 |  |  | — |
Astral field safety notification expenses (3) | — |  |  | 7,911 |  |  | — |
Acquisition related expenses | 2,031 |  |  | — |  |  | 10,949 |
Interest (income) expense, net | (4,114) |  |  | 45,708 |  |  | 47,379 |
(Gain) loss attributable to equity method investments | (3,644) |  |  | 1,848 |  |  | 7,265 |
(Gain) loss on equity investments | 10,299 |  |  | 4,045 |  |  | (9,922) |
Gain on insurance recoveries | — |  |  | — |  |  | (20,227) |
Other, net | 5,256 |  |  | 3,494 |  |  | 5,712 |
Income before income taxes | $ | 1,677,566 |  |  | $ | 1,264,798 |  |  | $ | 1,101,664 |
Depreciation and amortization by segment |  |  |  |  |
Sleep and Breathing Health | $ | 110,543 |  |  | $ | 86,070 |  |  | $ | 82,544 |
Residential Care Software | 9,467 |  |  | 10,241 |  |  | 9,119 |
Amortization of acquired intangible assets and corporate assets | 78,463 |  |  | 80,559 |  |  | 73,493 |
Total | $ | 198,473 |  |  | $ | 176,870 |  |  | $ | 165,156 |
(1) During the fiscal year ended June 30, 2024, we recorded $4.1 million of operating lease right-of-use asset impairments within our Residential Care Software segment. The impairments related to leases for office space and were recorded within selling, general and administrative expenses. (2) The masks with magnets field safety notification expenses relate to estimated costs to provide alternative masks to patients in response to updated contraindications for use of masks that incorporate magnets. (3) The Astral field safety notification expenses relate to estimated costs associated with the replacement of a certain component in some of our Astral ventilation devices that were manufactured between 2013 to 2019.
Schedule of Revenue by Segment, Product, and Region | The following table summarizes our net revenue disaggregated by segment, product and region for the years ended June 30, 2025, 2024 and 2023 (in thousands):
| 2025 |  | 2024 |  | 2023
U.S., Canada and Latin America |  |  |  |  |
Devices | $ | 1,654,413 |  |  | $ | 1,522,758 |  |  | $ | 1,444,361 |
Masks and other | 1,343,101 |  |  | 1,199,798 |  |  | 1,039,026 |
Total U.S., Canada and Latin America | $ | 2,997,514 |  |  | $ | 2,722,556 |  |  | $ | 2,483,387 |
Combined Europe, Asia and other markets |  |  |  |  |
Devices | $ | 1,010,760 |  |  | $ | 921,253 |  |  | $ | 826,341 |
Masks and other | 496,616 |  |  | 457,363 |  |  | 415,289 |
Total Combined Europe, Asia and other markets | $ | 1,507,376 |  |  | $ | 1,378,616 |  |  | $ | 1,241,630 |
Global revenue |  |  |  |  |
Devices | $ | 2,665,173 |  |  | $ | 2,444,011 |  |  | $ | 2,270,702 |
Masks and other | 1,839,717 |  |  | 1,657,161 |  |  | 1,454,315 |
Total Sleep and Breathing Health | $ | 4,504,890 |  |  | $ | 4,101,172 |  |  | $ | 3,725,017 |
Residential Care Software | 641,437 |  |  | 584,125 |  |  | 497,976 |
Total | $ | 5,146,327 |  |  | $ | 4,685,297 |  |  | $ | 4,222,993 |
Schedule of Revenue by Geographic Area | Revenue information by geographic area for the years ended June 30, 2025, 2024 and 2023 is summarized below (in thousands):
| 2025 |  | 2024 |  | 2023
United States | $ | 3,285,581 |  |  | $ | 2,980,053 |  |  | $ | 2,719,923 |
Rest of the World | 1,860,746 |  |  | 1,705,244 |  |  | 1,503,070 |
Total | $ | 5,146,327 |  |  | $ | 4,685,297 |  |  | $ | 4,222,993 |
Schedule of Long-Lived Assets by Geographic Areas | Long-lived assets by geographic area as of June 30, 2025 and 2024 is summarized below (in thousands):
| 2025 |  | 2024
Australia | $ | 170,836 |  |  | $ | 197,017 |
United States | 180,770 |  |  | 160,606 |
Singapore | 98,509 |  |  | 89,679 |
Rest of the World | 100,675 |  |  | 100,723 |
Total | $ | 550,790 |  |  | $ | 548,025 |

X
- Definition Schedule Of Revenue By Segment, Product, And Region [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfRevenueBySegmentProductAndRegionTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration